Flagship's Apriori Bio Aims to Predict COVID-19, Influenza, HIV Variants - BioSpace

7/12/2022 12:00:00 AM2 years 9 months ago
by Vanessa Doctor, RN

​​​​​​​Flagship Pioneering has launched Apriori Bio, which utilizes artificial intelligence to predict virus activity and variant formation, including COVID-19.

Noubar Afeyan/The Boston Globe/Getty Images In a busy 24 hours of launches, Flagship Pioneering announced Apriori Bio, which utilizes artificial intelligence to predict virus activity and variant fo… [+2922 chars]

full article...